<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39043760</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jul</Month><Day>24</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Clinical and endocrine features of orthostatic intolerance detected in patients with long COVID.</ArticleTitle><Pagination><StartPage>17025</StartPage><MedlinePgn>17025</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">17025</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-67815-y</ELocationID><Abstract><AbstractText>Orthostatic intolerance (OI) is a key symptom of long COVID; however, the pathophysiology remains unknown. Among 688 long COVID patients who visited our clinic during the period from February 2021 to April 2023, 86 patients who were suspected of having OI and who underwent an active standing test (ST) were investigated to elucidate the clinical characteristics of OI in patients with long COVID. Of the 86 patients, 33 patients (38%) were ST-positive. Nausea and tachycardia in daily life were frequent complaints in the ST-positive group. The increase in heart rate (HR) during the ST was significantly greater during a 10-min period after standing in the ST-positive group (+&#x2009;30&#xa0;bpm) than in the ST-negative group (+&#x2009;16&#xa0;bpm). The initial increase in diastolic blood pressure (DBP) just after standing was significantly greater in the ST-positive group (+&#x2009;14&#xa0;mmHg) than in the ST-negative group (+&#x2009;9&#xa0;mmHg). Serum cortisol levels in the ST-positive patients aged over 20&#xa0;years were higher and growth hormone levels in the patients under 20&#xa0;years of age were lower than those in the ST-negative group. Autonomous nervous symptoms, transient DBP rise with increasing HR after standing, and endocrine dysfunctions are helpful for detecting OI related to long COVID.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kato</LastName><ForeName>Atsushi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tokumasu</LastName><ForeName>Kazuki</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamamoto</LastName><ForeName>Koichiro</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otsuka</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakano</LastName><ForeName>Yasuhiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Honda</LastName><ForeName>Hiroyuki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sunada</LastName><ForeName>Naruhiko</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakurada</LastName><ForeName>Yasue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsuda</LastName><ForeName>Yui</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hasegawa</LastName><ForeName>Toru</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takase</LastName><ForeName>Ryosuke</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ueda</LastName><ForeName>Keigo</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otsuka</LastName><ForeName>Fumio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan. fumiotsu@md.okayama-u.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>22fk0108517h0001</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>WI4X0X7BPJ</RegistryNumber><NameOfSubstance UI="D006854">Hydrocortisone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054971" MajorTopicYN="Y">Orthostatic Intolerance</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="Y">Heart Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001794" MajorTopicYN="Y">Blood Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006854" MajorTopicYN="N">Hydrocortisone</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Active standing test</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Orthostatic intolerance</Keyword><Keyword MajorTopicYN="N">Post COVID-19 condition</Keyword><Keyword MajorTopicYN="N">Postural orthostatic tachycardia syndrome (POTS)</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>24</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>24</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>23</Day><Hour>23</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39043760</ArticleId><ArticleId IdType="pmc">PMC11266390</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-67815-y</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-67815-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nuzzo, J. B. &amp; Gostin, L. O. The first 2&#xa0;years of COVID-19: Lessons to improve preparedness for the next pandemic. JAMA327, 217&#x2013;218. 10.1001/jama.2021.24394 (2022). 10.1001/jama.2021.24394</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.24394</ArticleId><ArticleId IdType="pubmed">34989763</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi, G., Sanchis-Gomar, F. &amp; Henry, B. M. COVID-19 and its long-term sequelae: What do we know in 2023?. Pol. Arch. Intern. Med.10.20452/pamw.16402 (2023). 10.20452/pamw.16402</Citation><ArticleIdList><ArticleId IdType="doi">10.20452/pamw.16402</ArticleId><ArticleId IdType="pubmed">36626183</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, J. et al. Definition and measurement of post-COVID-19 conditions in real-world practice: A global systematic literature review. BMJ Open14, e077886. 10.1136/bmjopen-2023-077886 (2024). 10.1136/bmjopen-2023-077886</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2023-077886</ArticleId><ArticleId IdType="pmc">PMC10806676</ArticleId><ArticleId IdType="pubmed">38233057</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah, W., Hillman, T., Playford, E. D. &amp; Hishmeh, L. Managing the long term effects of COVID-19: Summary of NICE, SIGN, and RCGP rapid guideline. BMJ372, n136. 10.1136/bmj.n136 (2021). 10.1136/bmj.n136</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Otsuka, Y. et al. Clinical characteristics of Japanese patients who visited a COVID-19 aftercare clinic for post-acute sequelae of COVID-19/long COVID. Cureus13, e18568. 10.7759/cureus.18568 (2021). 10.7759/cureus.18568</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.18568</ArticleId><ArticleId IdType="pmc">PMC8571943</ArticleId><ArticleId IdType="pubmed">34760415</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokumasu, K. et al. Clinical characteristics of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) diagnosed in patients with long COVID. Medicina (Kaunas)10.3390/medicina58070850 (2022). 10.3390/medicina58070850</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58070850</ArticleId><ArticleId IdType="pmc">PMC9325226</ArticleId><ArticleId IdType="pubmed">35888568</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto, Y. et al. Utility of serum ferritin for predicting myalgic encephalomyelitis/chronic fatigue syndrome in patients with long COVID. J. Clin. Med.10.3390/jcm12144737 (2023). 10.3390/jcm12144737</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12144737</ArticleId><ArticleId IdType="pmc">PMC10381392</ArticleId><ArticleId IdType="pubmed">37510852</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani, M. et al. Autonomic dysfunction in &#x2018;long COVID&#x2019;: Rationale, physiology and management strategies. Clin. Med. (Lond.)21, e63&#x2013;e67. 10.7861/clinmed.2020-0896 (2021). 10.7861/clinmed.2020-0896</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0896</ArticleId><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuchida, T. et al. Treatment of long COVID complicated by postural orthostatic tachycardia syndrome&#x2014;Case series research. J. Gen. Fam. Med.25, 53&#x2013;61. 10.1002/jgf2.670 (2024). 10.1002/jgf2.670</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jgf2.670</ArticleId><ArticleId IdType="pmc">PMC10792321</ArticleId><ArticleId IdType="pubmed">38240001</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamrefors, V. et al. Syndromes of orthostatic intolerance and syncope in young adults. Open Heart4, e000585. 10.1136/openhrt-2016-000585 (2017). 10.1136/openhrt-2016-000585</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/openhrt-2016-000585</ArticleId><ArticleId IdType="pmc">PMC5471871</ArticleId><ArticleId IdType="pubmed">28674628</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladlow, P. et al. Dysautonomia following COVID-19 is not associated with subjective limitations or symptoms but is associated with objective functional limitations. Heart Rhythm19, 613&#x2013;620. 10.1016/j.hrthm.2021.12.005 (2022). 10.1016/j.hrthm.2021.12.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2021.12.005</ArticleId><ArticleId IdType="pmc">PMC8656177</ArticleId><ArticleId IdType="pubmed">34896622</ArticleId></ArticleIdList></Reference><Reference><Citation>Monaghan, A. et al. Orthostatic intolerance in adults reporting long COVID symptoms was not associated with postural orthostatic tachycardia syndrome. Front. Physiol.13, 833650. 10.3389/fphys.2022.833650 (2022). 10.3389/fphys.2022.833650</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2022.833650</ArticleId><ArticleId IdType="pmc">PMC8931464</ArticleId><ArticleId IdType="pubmed">35309052</ArticleId></ArticleIdList></Reference><Reference><Citation>Benarroch, E. E. Postural tachycardia syndrome: A heterogeneous and multifactorial disorder. Mayo Clin. Proc.87, 1214&#x2013;1225. 10.1016/j.mayocp.2012.08.013 (2012). 10.1016/j.mayocp.2012.08.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2012.08.013</ArticleId><ArticleId IdType="pmc">PMC3547546</ArticleId><ArticleId IdType="pubmed">23122672</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera Martimbianco, A. L., Pacheco, R. L., Bagattini, A. M. &amp; Riera, R. Frequency, signs and symptoms, and criteria adopted for long COVID-19: A systematic review. Int. J. Clin. Pract.75, e14357. 10.1111/ijcp.14357 (2021). 10.1111/ijcp.14357</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14357</ArticleId><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj, S. R. et al. Long-COVID postural tachycardia syndrome: An American Autonomic Society statement. Clin. Auton. Res.31, 365&#x2013;368. 10.1007/s10286-021-00798-2 (2021). 10.1007/s10286-021-00798-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-021-00798-2</ArticleId><ArticleId IdType="pmc">PMC7976723</ArticleId><ArticleId IdType="pubmed">33740207</ArticleId></ArticleIdList></Reference><Reference><Citation>Khosravani, H. The dysfunction is in the details: Neurovascular changes in COVID-19. Can. J. Neurol. Sci.48, 1&#x2013;2. 10.1017/cjn.2020.150 (2021). 10.1017/cjn.2020.150</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/cjn.2020.150</ArticleId><ArticleId IdType="pmc">PMC7545239</ArticleId><ArticleId IdType="pubmed">32665047</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunada, N. et al. Hormonal trends in patients suffering from long COVID symptoms. Endocr. J.69, 1173&#x2013;1181. 10.1507/endocrj.EJ22-0093 (2022). 10.1507/endocrj.EJ22-0093</Citation><ArticleIdList><ArticleId IdType="doi">10.1507/endocrj.EJ22-0093</ArticleId><ArticleId IdType="pubmed">35491089</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto, Y. et al. Detection of male hypogonadism in patients with post COVID-19 condition. J. Clin. Med.10.3390/jcm11071955 (2022). 10.3390/jcm11071955</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11071955</ArticleId><ArticleId IdType="pmc">PMC8999458</ArticleId><ArticleId IdType="pubmed">35407562</ArticleId></ArticleIdList></Reference><Reference><Citation>Otsuka, Y. &amp; Otsuka, F. Possibility of endocrine dysfunction in post coronavirus disease 2019 (COVID-19) condition. Endocr. J.69, 1357. 10.1507/endocrj.EJ22-0459 (2022). 10.1507/endocrj.EJ22-0459</Citation><ArticleIdList><ArticleId IdType="doi">10.1507/endocrj.EJ22-0459</ArticleId><ArticleId IdType="pubmed">36216578</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein, J. et al. Distinguishing features of long COVID identified through immune profiling. Nature623, 139&#x2013;148. 10.1038/s41586-023-06651-y (2023). 10.1038/s41586-023-06651-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06651-y</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Aizpurua-Perez, I., Arregi, A., Labaka, A., Martinez-Villar, A. &amp; Perez-Tejada, J. Psychological resilience and cortisol levels in adults: A systematic review. Am. J. Hum. Biol.35, e23954. 10.1002/ajhb.23954 (2023). 10.1002/ajhb.23954</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajhb.23954</ArticleId><ArticleId IdType="pubmed">37395446</ArticleId></ArticleIdList></Reference><Reference><Citation>Juruena, M. F., Bocharova, M., Agustini, B. &amp; Young, A. H. Atypical depression and non-atypical depression: Is HPA axis function a biomarker? A systematic review. J. Affect. Disord.233, 45&#x2013;67. 10.1016/j.jad.2017.09.052 (2018). 10.1016/j.jad.2017.09.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2017.09.052</ArticleId><ArticleId IdType="pubmed">29150144</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller, G. E., Chen, E. &amp; Zhou, E. S. If it goes up, must it come down? Chronic stress and the hypothalamic&#x2013;pituitary&#x2013;adrenocortical axis in humans. Psychol. Bull.133, 25&#x2013;45. 10.1037/0033-2909.133.1.25 (2007). 10.1037/0033-2909.133.1.25</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0033-2909.133.1.25</ArticleId><ArticleId IdType="pubmed">17201569</ArticleId></ArticleIdList></Reference><Reference><Citation>de Kloet, E. R. Glucocorticoid feedback paradox: A homage to Mary Dallman. Stress26, 2247090. 10.1080/10253890.2023.2247090 (2023). 10.1080/10253890.2023.2247090</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10253890.2023.2247090</ArticleId><ArticleId IdType="pubmed">37589046</ArticleId></ArticleIdList></Reference><Reference><Citation>Agorastos, A. &amp; Chrousos, G. P. The neuroendocrinology of stress: The stress-related continuum of chronic disease development. Mol. Psychiatry27, 502&#x2013;513. 10.1038/s41380-021-01224-9 (2022). 10.1038/s41380-021-01224-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-021-01224-9</ArticleId><ArticleId IdType="pubmed">34290370</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakurada, Y. et al. Trends in long COVID symptoms in Japanese teenage patients. Medicina (Kaunas)10.3390/medicina59020261 (2023). 10.3390/medicina59020261</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina59020261</ArticleId><ArticleId IdType="pmc">PMC9964697</ArticleId><ArticleId IdType="pubmed">36837463</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson, M. et al. Circulating levels of growth hormone in postural orthostatic tachycardia syndrome. Sci. Rep.11, 8575. 10.1038/s41598-021-87983-5 (2021). 10.1038/s41598-021-87983-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-87983-5</ArticleId><ArticleId IdType="pmc">PMC8060383</ArticleId><ArticleId IdType="pubmed">33883597</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi, A., Bernabei, R., Landi, F., Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA324, 603&#x2013;605. 10.1001/jama.2020.12603 (2020). 10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano, J. B. et al. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis.22, e102&#x2013;e107. 10.1016/S1473-3099(21)00703-9 (2022). 10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>in Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness The National Academies Collection: Reports funded by National Institutes of Health (2015).</Citation></Reference><Reference><Citation>Rowe, P. C. et al. Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers&#x2013;Danlos syndrome. J. Pediatr.135, 494&#x2013;499. 10.1016/s0022-3476(99)70173-3 (1999). 10.1016/s0022-3476(99)70173-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-3476(99)70173-3</ArticleId><ArticleId IdType="pubmed">10518084</ArticleId></ArticleIdList></Reference><Reference><Citation>Isojima, T. et al. Standardized centile curves and reference intervals of serum insulin-like growth factor-I (IGF-I) levels in a normal Japanese population using the LMS method. Endocr. J.59, 771&#x2013;780. 10.1507/endocrj.ej12-0110 (2012). 10.1507/endocrj.ej12-0110</Citation><ArticleIdList><ArticleId IdType="doi">10.1507/endocrj.ej12-0110</ArticleId><ArticleId IdType="pubmed">22673406</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>